StockViz
Share URL
Embed chart view
-
Export .csv
-
Download image
-
Copy link
-
Embed code
StockViz
RANKINGS
Novartis AG
Swiss Stock Exchange:NOVN.SW
Sector
Industries
Location
Market Cap
USD 242.02 B
Share Price
USD 122.54
Avg Daily Volume
3,462,718
Change (1 day)
0.36%
Change (1 year)
13.25%
Change (YTD)
24.93%
Novartis AG Revenue for the year ending December 31, 2024: USD 51.72 B
Novartis AG Revenue is USD 51.72 B for the year ending December 31, 2024, a 10.85% change year over year. Revenue is the total amount of money generated from the sales of goods or services by a company during a specific period.
-
Novartis AG Revenue for the year ending December 31, 2023 was USD 46.66 B, a -9.97% change year over year.
-
Novartis AG Revenue for the year ending December 31, 2022 was USD 51.83 B, a -1.98% change year over year.
-
Novartis AG Revenue for the year ending December 31, 2021 was USD 52.88 B, a 5.97% change year over year.
-
Novartis AG Revenue for the year ending December 31, 2020 was USD 49.90 B, a 2.51% change year over year.
Competitors
AbbVie Inc.
USD 189.77
ABBV
+2.14
1.14%
Novo Nordisk A/S
USD 70.59
NOVO-B.CO
+1.50
2.17%
Roche Holding AG
USD 342.36
RO.SW
+0.11
0.03%
Abbott Laboratories
USD 133.36
ABT
-0.34
-0.25%
AstraZeneca PLC
USD 140.42
AZN.L
+1.47
1.06%
Merck & Co., Inc.
USD 81.37
MRK
+0.47
0.58%
Amgen Inc.
USD 297.00
AMGN
+4.05
1.38%
Pfizer Inc.
USD 25.62
PFE
+0.38
1.51%
Gilead Sciences, Inc.
USD 111.06
GILD
-0.72
-0.64%
Vertex Pharmaceuticals Incorporated
USD 466.36
VRTX
+6.95
1.51%
Sanofi
USD 97.70
SAN.PA
+1.18
1.22%
Bristol-Myers Squibb Company
USD 47.04
BMY
+0.55
1.18%
Chugai Pharmaceutical Co., Ltd.
USD 46.38
4519.T
-0.70
-1.48%
CSL Limited
USD 159.49
CSL.AX
-1.10
-0.69%
GSK plc
USD 19.20
GSK.L
+0.23
1.19%
Regeneron Pharmaceuticals, Inc.
USD 547.75
REGN
+9.64
1.79%
MERCK Kommanditgesellschaft auf Aktien
USD 130.84
MRK.DE
+2.82
2.20%
Jiangsu Hengrui Medicine Co., Ltd.
USD 7.44
600276.SS
+0.11
1.44%
Takeda Pharmaceutical Company Limited
USD 29.98
4502.T
+0.01
0.04%
Alnylam Pharmaceuticals, Inc.
USD 317.50
ALNY
-6.63
-2.04%
Key Data
| Date | Revenue | Revenue | Gross Profit | Operating Income |
|---|
Competitors
AbbVie Inc.
USD 189.77
ABBV
+2.14
1.14%
Novo Nordisk A/S
USD 70.59
NOVO-B.CO
+1.50
2.17%
Roche Holding AG
USD 342.36
RO.SW
+0.11
0.03%
Abbott Laboratories
USD 133.36
ABT
-0.34
-0.25%
AstraZeneca PLC
USD 140.42
AZN.L
+1.47
1.06%
Merck & Co., Inc.
USD 81.37
MRK
+0.47
0.58%
Amgen Inc.
USD 297.00
AMGN
+4.05
1.38%
Pfizer Inc.
USD 25.62
PFE
+0.38
1.51%
Gilead Sciences, Inc.
USD 111.06
GILD
-0.72
-0.64%
Vertex Pharmaceuticals Incorporated
USD 466.36
VRTX
+6.95
1.51%
Sanofi
USD 97.70
SAN.PA
+1.18
1.22%
Bristol-Myers Squibb Company
USD 47.04
BMY
+0.55
1.18%
Chugai Pharmaceutical Co., Ltd.
USD 46.38
4519.T
-0.70
-1.48%
CSL Limited
USD 159.49
CSL.AX
-1.10
-0.69%
GSK plc
USD 19.20
GSK.L
+0.23
1.19%
Regeneron Pharmaceuticals, Inc.
USD 547.75
REGN
+9.64
1.79%
MERCK Kommanditgesellschaft auf Aktien
USD 130.84
MRK.DE
+2.82
2.20%
Jiangsu Hengrui Medicine Co., Ltd.
USD 7.44
600276.SS
+0.11
1.44%
Takeda Pharmaceutical Company Limited
USD 29.98
4502.T
+0.01
0.04%
Alnylam Pharmaceuticals, Inc.
USD 317.50
ALNY
-6.63
-2.04%